Filing metadata

Accession number
0001209191-22-032521
Form type
Form 3
Filer
KalVista Pharmaceuticals, Inc.
CIK
CIK 1348911
Filed
May 27, 2022
Reporting period
May 26, 2022
Description
Initial ownership

Explore SEC Filings Hub